Category Archives: Siegall

Clay Siegall and His Advanced Cancer Research

Seattle Genetics is a biotechnology company that focuses on the treatment of cancer. Seattle Genetics is the leader in developing antibody-drug conjugates (ADCs) which are a technology that sends cancer-fighting cells directly to the source. It was founded in 1998 by Clay B. Siegall, Ph.D. who is the company’s president, CEO, and chairman of the board. Siegall founded Seattle Genetics based on scientific innovation and rigorous research based on ADCs and the treatment of cancer cells.

Since it’s founding in 1998 Seattle Genetics has entered into multiple strategic licenses for their ADC development and they have generated over $325 to date. With Seattle Genetics new funding and money, they plan to create a diverse pipeline of proprietary ADCs to take the treatment of cancer one step further. Siegall and Seattle Genetics have been brought to the attention of many different journals and news outlets, one being Biz Journals where they discuss is an ambitious plan for twelve more drugs and the increase of employees to help work on the twelve new drugs.

Seattle Genetics is planning on focusing their continue research on Adcetris which is their only commercialized drug to date. Currently, they are performing seventy different trails with Adcetris but want to expand that to the next stage with more trails. With the expansion of trails and drug creation, it is allowing for Siegal to hire over one-hundred new employees.

Prior to Siegel’s role in co-founding Seattle Genetics, he was with Bristol-Myers Squibb Pharmaceutical Research Institute doing pharmaceutical research for over six years. It is no secret that Siegel is highly educated in the production of pharmaceutical drugs, and he has taken his expertise to tackle some of the most dangerous cells, cancer cells.

How Does Clay Siegall Plan To Help Seattle Genetics Expand Again

The Seattle Genetics name is one that Clay Siegall has built from scratch by making sure that he is helping people in a way that changes their lives after a cancer diagnosis. He created his own antibody therapy that he knows can help cancer patients, but he had to have a company that would help him to sell and market what he had created. What he did was create Seattle Genetics, and he has two drugs in trials that are doing very well. There was an earning call that told the public that they had nearly sold $100 million in a year, and they are now planning on making more drugs.

There are a lot of forms of cancer that people need to get treatment for, but the only way for these people to have results is to be sure that they have come to a company like Seattle Genetics. The company wants to begin production on new drugs to see how many cancers they can attack, and they want to be able to expand their company enough that they will have to make another move. They are getting so large that they will soon become one of the biggest in the industry.

Everyone who has had cancer or had someone who has been who has been hit by cancer needs to be sure that they are going to have the right drugs for their needs. Their needs are changing because there are so many different strains of cancer, and Clay Siegall believes that he can change things in a way that will help people in s a much more excellent way. He already has the trust of doctors in the industry, and he wants to show that he can create a new cancer drug that they can use with new patients.